Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

Cameron, D., Morden, J.P., Canney, P. et al. (21 more authors) (2017) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology, 18 (7). pp. 929-945. ISSN 1470-2045

Abstract

Metadata

Authors/Creators:
  • Cameron, D.
  • Morden, J.P.
  • Canney, P.
  • Velikova, G.
  • Coleman, R. ORCID logo https://orcid.org/0000-0002-4275-1043
  • Bartlett, J.
  • Agrawal, R.
  • Banerji, J.
  • Bertelli, G.
  • Bloomfield, D.
  • Brunt, A.M.
  • Earl, H.
  • Ellis, P.
  • Gaunt, C.
  • Gillman, A.
  • Hearfield, N.
  • Laing, R.
  • Murray, N.
  • Couper, N.
  • Stein, R.C.
  • Verrill, M.
  • Wardley, A.
  • Barrett-Lee, P.
  • Bliss, J.M.
Copyright, Publisher and Additional Information: © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. (https://creativecommons.org/licenses/by/4.0/)
Keywords: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Capecitabine; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Diarrhea; Disease-Free Survival; Epirubicin; Fatigue; Female; Filgrastim; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hand-Foot Syndrome; Humans; Infections; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Survival Rate; Time Factors
Dates:
  • Published (online): 7 June 2017
  • Published: July 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 03 Mar 2021 17:33
Last Modified: 03 Mar 2021 17:33
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/s1470-2045(17)30404-7
Related URLs:

Share / Export

Statistics